MiR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase

Cell Death and Disease

Volumn 5, Issue , 2014, Pages

  Chen, L ^a   Lu M H ^a   Zhang, D ^a   Hao, N B ^a   Fan, Y H ^a   Wu, Y Y ^a   Wang, S M ^a   Xie, R ^a   Fang, D C ^a   Zhang, H ^b   Hu, C J ^a   Yang, S M ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; MESSENGER RNA; MICRORNA 1207 5P; MICRORNA 1266; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; MICRORNA; MIRN1207 MICRORNA, HUMAN; MIRN1266 MICRORNA, HUMAN; TELOMERASE; TERT PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CANCER GROWTH; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GAIN OF FUNCTION MUTATION; GENE REPRESSION; GENE TARGETING; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR INVASION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; CELL PROLIFERATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; STOMACH TUMOR;

3' UNTRANSLATED REGIONS; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; STOMACH NEOPLASMS; TELOMERASE;

EID: 84957556436     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.553     Document Type: Article

References (41)

1. Noel JF, Wellinger RJ. Exposing secrets of telomere-Telomerase encounters. Cell 2012; 150: 453-454.
2. Nandakumar J, Cech TR. Finding the end: recruitment of telomerase to telomeres. Nat Rev Mol Cell Biol 2013; 14: 69-82.
3. Cifuentes-Rojas C, Shippen DE. Telomerase regulation. Mutat Res 2012; 730: 20-27.
4. Zhang Y, Chen X, Xu X, Wang X, Yuan G, Sun D et al. Knockdown of hTERT alters biophysical properties of K562 cells resulting in decreased migration rate in vitro. Cell Biochem Biophys 2011; 61: 595-603.
5. Lu MH, Deng JQ, Cao YL, Fang DC, Zhang Y, Yang SM. Prognostic role of telomerase activity in gastric adenocarcinoma: A meta-Analysis. Exp Ther Med 2012; 3: 728-734.
6. Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003; 24: 1167-1176.
7. Toffanin S, Villanueva A, Llovet JM. miRNA delivery: emerging therapy for hepatocellular carcinoma. Gastroenterology 2010; 138: 1202-1204.
8. Sprouse AA, Steding CE, Herbert BS. Pharmaceutical regulation of telomerase and its clinical potential. J Cell Mol Med 2012; 16: 1-7.
9. Liu X, Inomata M, Ogawara T, Saneyoshi M, Yamaguchi T. Telomere shortening in human HL60 cells by treatment with 30-Azido-20,30-dideoxynucleosides and telomerase inhibition by their 50-Triphosphates. Nucleosides Nucleotides Nucleic Acids 2007; 26: 1067-1071.
10. Rossi A, Russo G, Puca A, La Montagna R, Caputo M, Mattioli E et al. The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. Int J Cancer 2009; 125: 235-243.
11. Gryaznov SM. Oligonucleotide n30-4p50 phosphoramidates and thio-phoshoramidates as potential therapeutic agents. Chem Biodivers 2010; 7: 477-493.
12. Mahendar P, Sirisha K, Kulandaivelu U, Shankar PL, Radhika T, Sadanandam A. In silico evaluation of TERT inhibition by anticancer drugs. J Mol Model 2012; 18: 4739-4744.
13. Chakraborty S, Ghosh U, Bhattacharyya NP, Bhattacharya RK, Roy M. Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat Res 2006; 596: 81-90.
14. Vonderheide RH, Domchek SM, Schultze JL, George DJ, Hoar KM, Chen DY et al. Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes. Clin Cancer Res 2004; 10: 828-839.
15. Brunsvig PF, Aamdal S, Gjertsen MK, Kvalheim G, Markowski-Grimsrud CJ, Sve I et al. Telomerase peptide vaccination: A phase I/II study in patients with non-small cell lung cancer. Cancer Immunol Immunother 2006; 55: 1553-1564.
16. Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Eur J Cancer Prev 2008; 17: 209-217.
17. Chen L, Liang GP, Tang XD, Chen T, Cai YG, Fang DC et al. In vitro anti-Tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus. Biochem Biophys Res Commun 2006; 351: 927-934.
18. Chen L, Tang XD, Yu ST, Ai ZH, Fang DC, Cai YG et al. Induction of anti-Tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice. J Pathol 2009; 217: 685-692.
19. Yu ST, Chen L, Wang HJ, Tang XD, Fang DC, Yang SM. hTERT promotes the invasion of telomerase-negative tumor cells in vitro. Int J Oncol 2009; 35: 329-336.
20. Zhang RG, Zhao JJ, Yang LQ, Yang SM, Wang RQ, Chen WS et al. RNA interferencemediated hTERT inhibition enhances TRAIL-induced apoptosis in resistant hepatocellular carcinoma cells. Oncol Rep 2010; 23: 1013-1019.
21. Yu ST, Li C, Lu MH, Liang GP, Li N, Tang XD et al. Noninvasive and real-Time monitoring of the therapeutic response of tumors in vivo with an optimized hTERT promoter. Cancer-Am Cancer Soc 2012; 118: 1884-1893.
22. Mitomo S, Maesawa C, Ogasawara S, Iwaya T, Shibazaki M, Yashima-Abo A et al. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci 2008; 99: 280-286.
23. Kang JG, Majerciak V, Uldrick TS, Wang X, Kruhlak M, Yarchoan R et al. Kaposi's sarcoma-Associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J Pathol 2011; 225: 378-389.
24. Wang YY, Sun G, Luo H, Wang XF, Lan FM, Yue X et al. MiR-21 modulates hTERT through a STAT3-dependent manner on glioblastoma cell growth. Cns Neurosci Ther 2012; 18: 722-728.
25. Li C, Nie H, Wang M, Su L, Li J, Yu B et al. MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 2012; 320: 189-197.
26. Li J, Guo Y, Liang X, Sun M,Wang G, DeWet al. MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. J Cancer Res Clin Oncol 2012; 138: 763-774.
27. Yi C, Wang Q, Wang L, Huang Y, Li L, Liu L et al. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma. Oncogene 2012; 31: 4421-4433.
28. Zhao XH, Yang L, Hu JG. Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. J Exp Clin Canc Res 2011; 30: 55.
29. Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-Apoptotic gene EGR2. Biochem Biophys Res Commun 2010; 392: 340-345.
30. Zheng B, Liang L, Wang C, Huang S, Cao X, Zha R et al. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 2011; 17: 7574-7583.
31. Guo XB, Jing CQ, Li LP, Zhang L, Shi YL, Wang JS et al. Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene. World J Gastroenterol 2011; 17: 1895-1902.
32. Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM et al. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 2011; 10: 1.
33. Feng RH, Chen XH, Yu YY, Su LP, Yu BQ, Li JF et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010; 298: 50-63.
34. Papagregoriou G, Erguler K, Dweep H, Voskarides K, Koupepidou P, Athanasiou Y et al. A miR-1207-5p binding site polymorphism abolishes regulation of HBEGF and is associated with disease severity in CFHR5 nephropathy. PloS One 2012; 7: e31021.
35. Ichihara A, Jinnin M, Oyama R, Yamane K, Fujisawa A, Sakai K et al. Increased serum levels of miR-1266 in patients with psoriasis vulgaris. Eur J Dermatol 2012; 22: 68-71.
36. Mitra R, Bandyopadhyay S. MultiMiTar: A novel multi objective optimization based miRNA-Target prediction method. PloS One 2011; 6: e24583.
37. Zhao D, Wang Y, Luo D, Shi X, Wang L, Xu D et al. PMirP: A pre-microRNA prediction method based on structure-sequence hybrid features. Artif Intell Med 2010; 49: 127-132.
38. Yu ST, Yang YB, Liang GP, Li C, Chen L, Shi CM et al. An optimized telomerase-specific lentivirus for optical imaging of tumors. Cancer Res 2010; 70: 2585-2594.
39. Wang C, Gao DM, Guo K, Kang XN, Jiang K, Sun C et al. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model. Bmc Cancer 2012; 12: 166.
40. Xiong Z, Lu MH, Fan YH, Cao YL, Hu CJ, Wu YY et al. Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo. Int J Oncol 2012; 40: 1601-1609.
41. Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 2008; 7: 759-764.